Sponsored by Saxo

 

Good morning everyone, and welcome to July 31, 2024 – an important date in the history of stuff because of reasons.

It was on this day in 1853 that the first ever night-time surgery was performed, at Lychakiv Hospital in what is now known as the Ukrainian city of Lviv.

The surgeon’s work was illuminated by new kerosene oil lamps invented by Ignacy Łukasiewicz, and it was considered a roaring success, leading to the advent of day/night surgery in a bid to attract a fresh, new audience to televised surgical procedures.

And it was on this day in 1899 that, according to the history books, “Albert Trott hits Monty Noble over the Pavilion at Lord’s Cricket Ground”. Noble survived with just a few cuts and bruises.

And it was on this day in 1922 that a young man called Ralph Samuelson became the first person to successfully ride on waterskis.

I think we have some footage of that…

Yep! Here it is!

Amazing stuff. That young man is lucky to be alive.

Thankfully, you won’t need to risk your life and become the laughing stock of a generation of slack-jawed television lovers in order to get your hands on good pre-market info today.

That’s because – as always – we’ve worked super-hard to gather together lots of fiddly little things below, so you don’t need to go ferreting all over the internet for your ASX info this morning.

 

COMMODITY/FOREX/CRYPTO MARKET PRICES

Gold: US$2,389.06/oz (+0.33%)

Silver: US$27.83/oz (+0.05%)

Nickel (3mth): US$15,794/t (0.00%)

Copper (3mth): US$9,111/t (0.00%)

Zinc: US$2,669/t (0.00%)

Oil (WTI): US$75.63 (-0.24%)

Oil (Brent): US$79.60 (-0.23%)

Iron 62pc Fe: US$99.05/t (-2.61%)

AUD/USD: 0.6546 (-0.02%)

Bitcoin: US$67,794.60 (+0.04%)

 

WHAT GOT YOU TALKING

It’s quarterly season on the ASX – you can tell from all the screaming emanating from business newsrooms around the nation – but luckily for you, Nadine McGrath has done you an enormous favour by rounding up all the health stocks to see which ones did well before the end of the financial year.

 

 

YESTERDAY’S ASX SMALL CAP LEADERS

Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

 

Yesterday’s Small Cap Winners included:

African Gold (ASX:A1G) was flying quickly on Tuesday morning, on news of a maiden gold resource from the Blaffo Guetto prospect at the Didievi Project in  Cote d’Ivoire, which has come in at an inferred 4.93Mt for 452koz of gold at 2.9 g/t (1.0 g/t Au cut off). The company says that several key assays tell an exciting story, such as 10.0m at 123.0g/t gold from 66m including 2.0m at 613.0g/t gold, and 80.0m at 3.0g/t gold from surface, including 23.0m at 9.5g/t gold.

Small explorer Castle Minerals (ASX:CDT) delivered its quarterly, revealing that things are progressing much as you’d expect them to, with the company recently raising close to $600k in a placement to boost its warchest to around $1 million, while it continues its search for graphite and gold across three projects.

Appen (ASX:APX) also dropped its quarterly this morning, with mixed (but still mostly positive) news that revenue for Q2 FY24 was $55.0 million, down 16% on previous corresponding period – however, excluding Google revenue from the equation has the company’s revenue for Q2 FY24 grew 16% from $47.2 million in Q2 FY23.

Regener8 Resources (ASX:R8R) was up on news that the company has executed an agreement covering the  acquisition of tenement application ELA6755, known to its friends as North Achilles, in the Cobar district of western NSW. Regener8’s purchase lies approximately 2km along strike from Australian Gold and Copper (ASX:AGC) recent Achilles discovery, which has returned drill intercepts up to 5m @ 16.9g/t Au, 1,667g/t Ag, 0.4% Cu and 15% Pb + Zn.

RooLife Group (ASX:RLG) delivered its quarterly, and while it’s not an at-a-glance smash hit, it was enough to get investors excited. The company has, by the looks of things, been trimming some of the fat from the expense side of the ledger this past quarter, and while revenue was down the company still has a handy million or so in cash reserves.

Otto Energy’s (ASX:OEL) quarterly had some great news for shareholders, with the company reaffirming its decision to give as much money as it can back to investors. Otta says it had $60.8 million in cash balances at the end of the quarter – and after the proposed return of capital of up to $40 million, will still have at least $20.8 million of cash at bank – and will, from time to time, continue to look for ways to hand it out.

SaaS technology company AD1 Holdings (ASX:AD1) released its quarterly this morning, and investors were enjoying what it had to say. AD1 says that its North American business has grown by over 100%, a rebranding is well underway and the company has about 200 grand in the bank.

DXN (ASX:DXN) revealed in its quarterly report that total revenue for the quarter of $3.8 million was up 145% over this time last year, (4Q23: $1.6 million). FY24 revenue rose 41% to $10.9 million – up from $7.8 million in FY23, adding that sales growth has been driven by the deployment of new modular data centre sales across multiple clients.

Elixinol Global (ASX:EXL) issued its quarterly, and it’s jam-packed with healthy news that’s tasty as well. Q2 Group revenue was up 118% to $3.7 million from $1.7M a year ago, and that represents the seventh consecutive quarter of revenue growth. Additionally, record Q2 sales of $3.2 million are a twofold increase over Q2 FY23, a 29% improvement on Q1’s $2.5 million and have handed Elixinol an unaudited H1 revenue that has almost doubled to $6.8 million from $3.5 million on PCP.

Later in the day, Carnavale Resources (ASX:CAV) delivered a quarterly that got investors jiggling this arvo, despite there being no ‘fresh news’ in it – but as far as “we’ve had a cracker of a quarter” reports go, Carnavale’s was pretty solid, highlighting the work the company has completed and reminding us all that they have a MRE from the Swiftsure deposit at the Kookynie Gold Project that clocks in at 457kt @ 5.8g/t for 85koz. Mmmm… juicy.

Bioxyne (ASX:BXN) dropped its quarterly as well, revealing that it took in revenue of $3.1 million for the quarter, taking the company’s full year total to $9.43 million – which is a 25% increase on the aggregated revenue for FY2023 of $7.5 million. Bioxyne also noted that it’s back on track after some third-party delays, with its milestone of being awarded Australia’s first GMP certification for psilocybin and MDMA following rescheduling of these medicines heralded as a monumental achievement by the board.

 

YESTERDAY’S ASX SMALL CAP LAGGARDS

Here are the worst performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Wordpress Table Plugin

 

TRADING HALTS 

African Gold (ASX:A1G) – pending an announcement updating the market on the Exploration Target for the Didievi Project.

State Gas (ASX:GAS) – pending an announcement regarding a material financing transaction and an accelerated non-renounceable entitlement offer.

Elementos (ASX:ELT) – for the purpose of considering and executing a proposed capital raising.

QMines (ASX:QML) – ending the release of an announcement in relation to a proposed equity raise.

South Harz Potash (ASX:SHP) – for the purpose of considering, planning and executing a capital raising.

PM Capital Global Opportunities Fund Limited (ASX:PGF) – pending an announcement to ASX in connection with a capital raising.

Read MoreMarkets

Featured Companies

You might be interested in